STAT
JUNE 6, 2023
On the other, for those who are not vulnerable or immune compromised, most facets of life have returned to normal, thanks to high levels of immunity from vaccines, boosters, and past infections. One of the last vestiges of the pandemic seems to be mask mandates in hospitals, which are now being lifted in the U.S. In the U.S.,
STAT
NOVEMBER 24, 2022
An experimental influenza vaccine developed using messenger RNA technology appears capable of inducing what should be a protective immune response against all known subtypes of flu, at least in animals. If the work is translated into humans it could turn out to be a version of a long-sought universal vaccine. Read the rest…
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JULY 20, 2023
WASHINGTON — Hospitals for years have complained that Medicare pays so little for CAR-T cancer treatments that they sometimes lose money administering the incredibly expensive treatments. CAR-T uses the body’s own immune system to kill cancerous cells. Continue to STAT+ to read the full story…
STAT
DECEMBER 12, 2022
had relied upon so-called “natural immunity” acquired through infection as the only immunological defense against the virus. times more hospitalizations in the time since December of 2020. But the study results show the toll would have been even worse had the U.S. times more infections, and 3.8
STAT
MAY 10, 2023
Brigham and Women’s Hospital will launch a new institute focused on immunology and inflammation, thanks to a $100 million gift, the largest in the hospital’s history. The institute will also investigate the aging of the immune system and immune dysfunction in cancer.
STAT
MAY 15, 2024
Immune cells have to be removed from a patient, shipped to specialty sites, where they’re engineered with cancer-killing abilities, and then returned to the hospital for infusion back into patients. CAR-Ts have proven to be potent treatments for certain cancers, but they are complicated medicines to make.
STAT
DECEMBER 5, 2023
About a decade ago, Mike Jensen, a pediatric oncologist at Seattle Children’s hospital, licensed to a startup his designs for a powerful new type of therapy, called CAR-T, that would re-engineer a child’s own immune cells to target cancer. The deal proved be a mixed blessing.
Expert insights. Personalized for you.
355 
Let's personalize your content